Keyphrases
Breast Cancer Imaging
100%
Beacon-based
100%
Cancer Targeting
100%
Nanoparticles
100%
Targeted Therapy
100%
Molecular Beacon
100%
Triple-negative Breast Cancer
100%
Metastatic Breast Cancer
50%
Matrix metalloproteinase-9 (MMP-9)
33%
Multifunctional Nanoparticles
33%
Breast Cancer
33%
Tumor Site
33%
Theranostic Nanoparticles
33%
Imaging Techniques
33%
Probe-based
33%
Breast Cancer Treatment
33%
Anticancer Drugs
33%
Annexin A2 (ANXA2)
33%
African American Women
33%
Novel Therapies
16%
Human Epidermal Growth Factor Receptor 2 (HER2)
16%
Methods for Detection
16%
Herceptin
16%
Disease Severity
16%
Therapeutic Target
16%
High Mortality Rate
16%
In Vivo Validation
16%
Targeted Delivery
16%
Mouse Tumor Model
16%
PH-responsive
16%
Multimodal Approach
16%
PDLLA
16%
Time Gating
16%
Drug Therapy
16%
Next-generation Medicine
16%
Multi-model Approach
16%
Uptake Studies
16%
Diagnostic Accuracy
16%
Tumor Chemotherapy
16%
Theranostic Strategy
16%
All-in-one Machine
16%
Specific Intent
16%
In Vivo Imaging
16%
Docetaxel
16%
Surface Conjugation
16%
Drug Response
16%
Breast Cancer Cell Lines
16%
Clinical Potential
16%
Drug Nanoparticles
16%
Anticancer Agents
16%
Biodegradable Polymeric Nanoparticles
16%
Breast Cancer Diagnosis
16%
Progesterone Receptor
16%
Estrogen Receptor
16%
Intracellular Uptake
16%
Tumor Imaging
16%
Medicine and Dentistry
Targeted Therapy
100%
Triple Negative Breast Cancer
100%
Nanoparticle
100%
Breast Cancer
33%
Metastatic Breast Cancer
33%
Anticarcinogen
33%
Cancer Therapy
22%
Neoplasm
22%
Polyethylene Glycol
22%
Imaging Technique
22%
Gelatinase B
22%
Biological Marker
22%
Medicine
11%
Lipocortin 2
11%
Diagnosis
11%
Breast Cancer Cell Line
11%
Estrogen Receptor Beta
11%
Progesterone Receptor
11%
Trastuzumab
11%
Drug Therapy
11%
Docetaxel
11%
Cancer Diagnosis
11%
Mortality Rate
11%
Cancer Chemotherapy
11%
Diseases
11%
Pharmacology, Toxicology and Pharmaceutical Science
Nanoparticle
100%
Triple Negative Breast Cancer
100%
Breast Cancer
44%
Neoplasm
33%
Anticarcinogen
33%
Metastatic Breast Cancer
33%
Polyethylene Glycol
22%
Biological Marker
22%
Gelatinase B
22%
Pharmacotherapy
11%
Mortality Rate
11%
Progesterone Receptor
11%
Trastuzumab
11%
Estrogen Receptor Beta
11%
Lipocortin 2
11%
Mouse Model
11%
Docetaxel
11%
Chemotherapy
11%
Diseases
11%